Apr. 16, 2026
Kisses From Italy Announces Rapid Expansion and New Leadership After Regen Health Merger
The company is pivoting into the high-growth biologics and longevity sector with a focus on regenerative medicine and peptide therapy.
Apr. 16, 2026
Healthcare Supply Chain IT Now a Margin-Control Issue, Black Book Warns Boards
New report finds weak visibility, slow substitute approvals, and manual workflows eroding margins and care continuity
Apr. 16, 2026
Biopharmas Pull Back on Layoffs in Q1
The trend of fewer companies letting employees go continues, but more were affected in Q1 2026 than in Q1 2025.
Apr. 16, 2026
MShape Beauty Secures Exclusive U.S. Distribution for Advanced Body Sculpting Tech
New agreement expands access to EMSHAPE® NEO and PERFECT SHAPE® NEO systems nationwide
Apr. 15, 2026
AngioDynamics Touts Debt-Free Turnaround, Auryon Gains, and NanoKnife Launch
CEO highlights growth drivers in MedTech segment and clinical plans for key platforms at Needham Healthcare Conference.
Apr. 15, 2026
AngioDynamics CEO Highlights Debt-Free Turnaround, Auryon Gains, and NanoKnife Launch
Clemmer touts MedTech growth, outlines plans for key platforms at Needham Healthcare Conference
Apr. 15, 2026
Mesoblast Acquires CAR Platform License From Mayo
Rights came via a Mayo-linked startup, and Mayo will provide GMP support. Mesoblast sees near-term use in ulcerative colitis, Crohn's and lupus.
Apr. 15, 2026
Kisses from Italy Announces Rapid Expansion and New Leadership After Regen Health Acquisition
The company is positioning itself for national growth by leveraging Regen Health's proven medical platform and franchise model.
Apr. 15, 2026
Mesoblast Acquires Chimeric Antigen Receptor Tech
The global leader in cellular medicines expands its precision-enhanced cell product platform.
Apr. 14, 2026
OSE Immunotherapeutics Enhances Leadership Team
Appoints Thomas Gidoin as Deputy CEO and Aurore Morello as Chief Scientific Officer
